Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole Safety in Pediatric Invasive Aspergillosis
NCT00836875Phase 3Terminated
- Sponsor
- Pfizer
- Start
- May 2009
- Primary completion
- May 2013
- Modality
- Orthosteric Ligands
- Countries
- 8
01
Overview
A Phase 3 trial of voriconazole in invasive aspergillosis (IA), scedosporiosis, fusariosis, sponsored by Pfizer. Started May 2009; status: terminated.
02
Drugs
voriconazole
03
Conditions
invasive aspergillosis (IA)scedosporiosisfusariosis
Beyond the preview
Go deeper on NCT00836875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00836875.